Report on the 11th Neuromuscular Translational Research Conference in April 2018
More than 200 delegates from around the world attended the conference held on 19th and 20th April in Fitzwilliam College, […]
Continue Reading
More than 200 delegates from around the world attended the conference held on 19th and 20th April in Fitzwilliam College, […]
Continue ReadingNantes, France – May 22th, 2018. InFlectis BioScience SAS, a drug discovery company committed to the development of innovative therapeutics […]
Continue ReadingResearchers have found that disease progression in Charcot-Marie-Tooth type 1A (CMT1A) patients reaches a critical point at age 50, after which […]
Continue ReadingROSE Brewis was an adult before she discovered she had progressive muscle-wasting disease CMT which affects thousands in the UK. […]
Continue ReadingDr Shevchuk and his team have established a method that allows them to study the effects of mutations in the […]
Continue ReadingCHARCOT-MARIE-TOOTH is a neurological, incurable condition which can cause symptoms including uncontrollable pain and chronic fatigue. Charcot-Marie-Tooth (CMT) can also […]
Continue ReadingLast Updated: Saturday 24th November, 2018